Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 708

Sort by

Sort Order Select

Journal Articles

Clinical-genomic profiling of MDS to inform allo-HSCT:Recommendations from an international panel on behalf of the EBMT

Blood blood.2024025131.

https://doi.org/10.1182/blood.2024025131

Published: 2025

Includes: Supplemental data

Journal Articles

Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion

Blood (2024) 144 (16): 1722–1731.

https://doi.org/10.1182/blood.2024023840

Published: 2024

Includes: Supplemental data

Journal Articles

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

Carmelo Gurnari, Hussein Awada, Simona Pagliuca, Danai Dima, Fauzia Ullah, Naomi Kawashima, Yasuo Kubota, Ceylan Colak, Valeria Visconte, Bhumika J. Patel, Vikram Dhillon, Naimisha Marneni, Suresh Kumar Balasubramanian, Ashwin Kishtagari, Taha Bat, Jaroslaw P. Maciejewski

Blood (2024) 144 (2): 145–155.

https://doi.org/10.1182/blood.2024023988

Published: 2024

Journal Articles

Association Vs Causation: Epidemiologic Clues As to the Autoimmune Pathogenesis of MDS

Nakisha D Williams, Arda Durmaz, Carlos Bravo-Perez, Yasuo Kubota, Megan Reynold, Michaela Witt, Luca Guarnera, Morgan Ferrel, Aashray Mandala, Naomi Kawashima, Carmelo Gurnari, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 4066.

https://doi.org/10.1182/blood-2023-181916

Published: 2023

Journal Articles

Categorization of Hematological Responses to Oral Iptacopan Monotherapy in Anti-C5-Treated Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia in the Phase III APPLY-PNH Trial and Complement Inhibitor-Naïve Patients in the Phase III APPOINT-PNH Trial

Antonio M Risitano, Bing Han, Austin Kulasekararaj, Yasutaka Ueda, Phillip Scheinberg, Carlos de Castro, Jaroslaw P. Maciejewski, Josefin Snellman, Ranjan Tiwari, Marion Dahlke, Régis Peffault de Latour

Blood (2023) 142 (Supplement 1): 4084.

https://doi.org/10.1182/blood-2023-180866

Published: 2023

Journal Articles

Differential Isoforms Signature of Splicing Factor Mutant Myeloid Neoplasia

Arda Durmaz, Carmelo Gurnari, Carlos Bravo-Perez, Luca Guarnera, Yasuo Kubota, Naomi Kawashima, Ishani Nautiyal, Sean Yetter, Nakisha D Williams, Serhan Unlu, Sindhusha Veeraballi, Arooj Ahmed, Chao-Yie Yang, John Barnard, Jacob Scott, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 5701.

https://doi.org/10.1182/blood-2023-184752

Published: 2023

Journal Articles

Co-Occurring Mutations in ASXL1 and SRSF2 Define a Unique, Prognostically Relevant Chromatin-Spliceosome Gene Signature in De Novo acute Myeloid Leukemia

Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 4321.

https://doi.org/10.1182/blood-2023-191331

Published: 2023

Journal Articles

Validation of the Composite Complete Response (cCR) Definitions in the International Working Group (IWG) 2023 Criteria in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) Treated with Hypomethylating Agents (HMA) - a Large, Multicenter, Retrospective Analysis from the Validate Database

Blood (2023) 142 (Supplement 1): 324.

https://doi.org/10.1182/blood-2023-180299

Published: 2023

Journal Articles

Small-Molecule U2 Auxiliary Factor Homology Motif (UHM) Domain Inhibitors Cause Splicing Pattern Changes in U2AF1 Mutant Leukemia Cells and Induce Sub-G1 Cell Cycle Arrest

Chao-Yie Yang, Xinrui Yuan, Mona Kazemi Sabzvar, Arda Durmaz, Krishnapriya Chinnaswamy, Jeanne Stuckey, Seth J Corey, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 115.

https://doi.org/10.1182/blood-2023-190365

Published: 2023

Journal Articles

Branching Trajectories and Diversification of Clonal Escape in Aplastic Anemia Revealed By Single-Cell Genomics

Masanori Yoshida, Paula Arnold, Carmelo Gurnari, Charnise Goodings, Shinsuke Hirabayashi, Miriam Erlacher, Jaroslaw P. Maciejewski, Charlotte Marie Niemeyer, Marcin W Wlodarski

Blood (2023) 142 (Supplement 1): 705.

https://doi.org/10.1182/blood-2023-186205

Published: 2023

Journal Articles

Biallelic Landscape of DNMT3A Mutant Myeloid Neoplasia

Naomi Kawashima, Yasuo Kubota, Carmelo Gurnari, Carlos Bravo-Perez, Luca Guarnera, Nakisha D Williams, Arda Durmaz, Megan Reynold, Arooj Ahmed, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 1469.

https://doi.org/10.1182/blood-2023-181793

Published: 2023

Journal Articles

Geno-Multiomics Strategy Informs Drug Response Profiles in High-Risk Myeloid Neoplasia

Arda Durmaz, Sean Yetter, Tariq Kewan, Waled Bahaj, Carlos Bravo-Perez, Luca Guarnera, Naomi Kawashima, Hussein Awada, Carmelo Gurnari, Yasuo Kubota, Jacob Scott, Jaroslaw P. Maciejewski, Valeria Visconte

Blood (2023) 142 (Supplement 1): 5016.

https://doi.org/10.1182/blood-2023-190059

Published: 2023

Journal Articles

Predicting Clonal Evolution to Secondary Myeloid Neoplasms in Aplastic Anemia through Machine Learning

Ahmet Celal Toprak, Taha Bat, Mutlu Mete, Carmelo Gurnari, Zoe Bass, Jaroslaw P. Maciejewski, Hussein Awada, Alper Olcal, Ibrahim F. Ibrahim

Blood (2023) 142 (Supplement 1): 4093.

https://doi.org/10.1182/blood-2023-191141

Published: 2023

Journal Articles

Impact of Type of Hypomethylating Agent (HMA) Used on Outcomes of Patients (Pts) with Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) - a Large, Multicenter, Retrospective Analysis

Blood (2023) 142 (Supplement 1): 4613.

https://doi.org/10.1182/blood-2023-178728

Published: 2023

Journal Articles

HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2 V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study

Yu-Hung Wang, Carmelo Gurnari, Chao-Hung Wei, Hussein Awada, Chien-Chin Lin, Andrius Zucenka, Chi-Yuan Yao, Kristian Gurashi, Hsin-An Hou, Kiran Batta, Wen-Chien Chou, Jaroslaw P. Maciejewski, Daniel H Wiseman, Hwei-Fang Tien

Blood (2023) 142 (Supplement 1): 627.

https://doi.org/10.1182/blood-2023-179907

Published: 2023

Journal Articles

Evaluation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) with Missing Molecular Data

Blood (2023) 142 (Supplement 1): 4607.

https://doi.org/10.1182/blood-2023-187053

Published: 2023

Journal Articles

Bone Marrow Failure and Inborn Errors of Immunity: An Immunogenomic Crossroad

Carlos Bravo-Perez, Carmelo Gurnari, Luca Guarnera, Naomi Kawashima, Serhan Unlu, Aashray Mandala, Nakisha D Williams, Arooj Ahmed, Yasuo Kubota, Arda Durmaz, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 707.

https://doi.org/10.1182/blood-2023-183000

Published: 2023

Journal Articles

Unveiling the Spectrum of Inborn Errors of Immunity: Lessons from T-Cell LGL Clonal Expansions

Carlos Bravo-Perez, Carmelo Gurnari, Luca Guarnera, Naomi Kawashima, Serhan Unlu, Aashray Mandala, Mark Orland, Olisaemeka Ogbue, Nakisha D Williams, Arooj Ahmed, Yasuo Kubota, Arda Durmaz, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 154.

https://doi.org/10.1182/blood-2023-182344

Published: 2023

Journal Articles

Metabolic Signatures and Pathway Rewiring in TET2-Mutated Myeloid Neoplasia

Xiaorong Gu, Dongxu Jiang, Simon Schlanger, Nakisha D Williams, Divya Jyoti Singh, Daniel Vail, Jill Durkin, Yahan Zhang, Valeria Visconte, Jaroslaw P. Maciejewski, Babal Kant Jha

Blood (2023) 142 (Supplement 1): 2747.

https://doi.org/10.1182/blood-2023-189228

Published: 2023

Journal Articles

Validation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Who Underwent Allogenic Stem Cell Transplantation (HSCT)

Blood (2023) 142 (Supplement 1): 4980.

https://doi.org/10.1182/blood-2023-186578

Published: 2023

NARROW

Clinical-genomic profiling of MDS to inform allo-HSCT:Recommendations from an international panel on behalf of the EBMT

Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

Association Vs Causation: Epidemiologic Clues As to the Autoimmune Pathogenesis of MDS

Categorization of Hematological Responses to Oral Iptacopan Monotherapy in Anti-C5-Treated Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia in the Phase III APPLY-PNH Trial and Complement Inhibitor-Naïve Patients in the Phase III APPOINT-PNH Trial

Differential Isoforms Signature of Splicing Factor Mutant Myeloid Neoplasia

Co-Occurring Mutations in ASXL1 and SRSF2 Define a Unique, Prognostically Relevant Chromatin-Spliceosome Gene Signature in De Novo acute Myeloid Leukemia

Small-Molecule U2 Auxiliary Factor Homology Motif (UHM) Domain Inhibitors Cause Splicing Pattern Changes in U2AF1 Mutant Leukemia Cells and Induce Sub-G1 Cell Cycle Arrest

Branching Trajectories and Diversification of Clonal Escape in Aplastic Anemia Revealed By Single-Cell Genomics

Biallelic Landscape of DNMT3A Mutant Myeloid Neoplasia

Geno-Multiomics Strategy Informs Drug Response Profiles in High-Risk Myeloid Neoplasia

Predicting Clonal Evolution to Secondary Myeloid Neoplasms in Aplastic Anemia through Machine Learning

Impact of Type of Hypomethylating Agent (HMA) Used on Outcomes of Patients (Pts) with Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) - a Large, Multicenter, Retrospective Analysis

HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2 V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study

Evaluation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) with Missing Molecular Data

Bone Marrow Failure and Inborn Errors of Immunity: An Immunogenomic Crossroad

Unveiling the Spectrum of Inborn Errors of Immunity: Lessons from T-Cell LGL Clonal Expansions

Metabolic Signatures and Pathway Rewiring in TET2-Mutated Myeloid Neoplasia

Validation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Who Underwent Allogenic Stem Cell Transplantation (HSCT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only